Photo: Hindustan Times
SEC Recommends Corbevax COVID-19 Vaccine For 5-12 Year Old
The Subject Expert Committee (SEC) or the Drugs Controller General of India (DCGI) recommended the Corbevax COVID-19 vaccine for children between the 5 to 12-year-old age group. On April 21, the government panel said the vaccine is effective in children and has been recommended after trials. Furthermore, the final approval for the emergency use authorization (EUA) of Corbevax would be given by the DCGI soon.
Courtesy
